New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 23, 2013
06:21 EDTUTHRUnited Therapeutics upgraded to Neutral from Underweight at JPMorgan
JPMorgan upgraded United Therapeutics to Neutral with a $90 price target after the company received FDA approval for Orenitram.
News For UTHR From The Last 14 Days
Check below for free stories on UTHR the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
April 10, 2014
07:24 EDTUTHRInternational Society for Heart & Lung Transplantation to hold annual meeting
Subscribe for More Information
April 8, 2014
07:22 EDTUTHRCaSA-ISPE to hold a conference
21st Annual Lilfe Sciences Technology Conference is being held in Raleigh, North Carolina on April 8.
April 7, 2014
11:17 EDTUTHRUnited Therapeutics upgraded to Buy from Hold at Standpoint Research
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use